 Catherine Flaitz
Concepts (766)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dental Caries | 54 | 2017 | 172 | 4.150 |
Why?
| | Mouth Diseases | 19 | 2018 | 38 | 2.780 |
Why?
| | Mouth Neoplasms | 21 | 2012 | 70 | 2.270 |
Why?
| | Cariostatic Agents | 22 | 2014 | 29 | 2.040 |
Why?
| | Diagnosis, Differential | 53 | 2014 | 1357 | 1.870 |
Why?
| | Fluorides | 22 | 2014 | 45 | 1.810 |
Why?
| | Gingival Diseases | 11 | 2012 | 15 | 1.800 |
Why?
| | Dental Enamel | 30 | 2007 | 64 | 1.650 |
Why?
| | Tongue Neoplasms | 5 | 2013 | 20 | 1.430 |
Why?
| | Mouth Mucosa | 20 | 2014 | 79 | 1.410 |
Why?
| | Mandibular Neoplasms | 13 | 2003 | 22 | 1.160 |
Why?
| | Precancerous Conditions | 5 | 2013 | 156 | 1.020 |
Why?
| | AIDS-Related Opportunistic Infections | 15 | 2005 | 117 | 1.020 |
Why?
| | Tooth Remineralization | 8 | 2007 | 12 | 0.970 |
Why?
| | Dental Restoration, Permanent | 10 | 2003 | 40 | 0.960 |
Why?
| | Tooth, Deciduous | 11 | 2006 | 15 | 0.960 |
Why?
| | Ethics, Dental | 3 | 2013 | 3 | 0.940 |
Why?
| | Mandibular Diseases | 6 | 2007 | 9 | 0.910 |
Why?
| | Carcinoma, Squamous Cell | 8 | 2013 | 577 | 0.870 |
Why?
| | Lichen Planus, Oral | 3 | 2013 | 5 | 0.870 |
Why?
| | HIV Infections | 30 | 2013 | 2473 | 0.770 |
Why?
| | Lip Diseases | 5 | 2013 | 6 | 0.770 |
Why?
| | Molar | 18 | 2014 | 44 | 0.770 |
Why?
| | Gingival Neoplasms | 5 | 2001 | 10 | 0.740 |
Why?
| | Pit and Fissure Sealants | 9 | 2007 | 19 | 0.730 |
Why?
| | Humans | 216 | 2018 | 115587 | 0.710 |
Why?
| | Gingiva | 4 | 2012 | 22 | 0.700 |
Why?
| | Odontogenic Tumors | 6 | 2001 | 9 | 0.630 |
Why?
| | Glossitis | 3 | 2003 | 3 | 0.600 |
Why?
| | Burns, Chemical | 2 | 2012 | 25 | 0.590 |
Why?
| | Fluorides, Topical | 9 | 2004 | 16 | 0.570 |
Why?
| | Sarcoma, Kaposi | 8 | 2002 | 69 | 0.560 |
Why?
| | Drugs, Chinese Herbal | 1 | 2016 | 13 | 0.530 |
Why?
| | Tongue | 7 | 2004 | 67 | 0.510 |
Why?
| | Saliva | 8 | 2003 | 189 | 0.510 |
Why?
| | Laser Therapy | 12 | 2006 | 99 | 0.510 |
Why?
| | Male | 87 | 2017 | 55949 | 0.500 |
Why?
| | Maxillary Diseases | 4 | 2012 | 7 | 0.490 |
Why?
| | Child | 54 | 2018 | 18488 | 0.480 |
Why?
| | Condylomata Acuminata | 2 | 2013 | 6 | 0.480 |
Why?
| | Acidulated Phosphate Fluoride | 12 | 2007 | 12 | 0.480 |
Why?
| | Radiography | 19 | 2007 | 826 | 0.480 |
Why?
| | Resin Cements | 7 | 2010 | 24 | 0.470 |
Why?
| | Dental Sac | 1 | 2014 | 1 | 0.470 |
Why?
| | Gingival Hypertrophy | 1 | 2014 | 1 | 0.470 |
Why?
| | Dental Bonding | 6 | 2010 | 30 | 0.470 |
Why?
| | Herpesvirus 4, Human | 9 | 2007 | 123 | 0.460 |
Why?
| | Candidiasis, Oral | 12 | 2007 | 18 | 0.460 |
Why?
| | Root Caries | 9 | 2014 | 10 | 0.450 |
Why?
| | Dental Plaque | 6 | 2004 | 15 | 0.450 |
Why?
| | Granular Cell Tumor | 2 | 2003 | 7 | 0.430 |
Why?
| | Carcinoma, Mucoepidermoid | 4 | 2000 | 15 | 0.430 |
Why?
| | Salivary Gland Neoplasms | 4 | 2000 | 31 | 0.420 |
Why?
| | Odontogenic Cysts | 1 | 2012 | 1 | 0.410 |
Why?
| | Purpura | 1 | 2012 | 12 | 0.400 |
Why?
| | Dentifrices | 3 | 2014 | 4 | 0.400 |
Why?
| | Leukoplakia, Hairy | 8 | 2004 | 8 | 0.400 |
Why?
| | Ethics, Professional | 1 | 2011 | 15 | 0.390 |
Why?
| | Jaw Diseases | 2 | 2005 | 3 | 0.390 |
Why?
| | Analysis of Variance | 22 | 2007 | 1227 | 0.390 |
Why?
| | Gingivitis | 2 | 2010 | 11 | 0.390 |
Why?
| | Composite Resins | 7 | 2010 | 103 | 0.380 |
Why?
| | Tooth Diseases | 2 | 2001 | 13 | 0.380 |
Why?
| | Gingival Hyperplasia | 1 | 2010 | 3 | 0.380 |
Why?
| | Child, Preschool | 30 | 2017 | 9133 | 0.370 |
Why?
| | Oral Ulcer | 7 | 2003 | 9 | 0.370 |
Why?
| | Cheek | 2 | 2000 | 16 | 0.360 |
Why?
| | Gingivitis, Necrotizing Ulcerative | 5 | 2003 | 5 | 0.360 |
Why?
| | Sodium Fluoride | 8 | 2013 | 15 | 0.360 |
Why?
| | HIV Seropositivity | 4 | 2007 | 110 | 0.360 |
Why?
| | Female | 71 | 2017 | 59913 | 0.350 |
Why?
| | Lithiasis | 1 | 2009 | 3 | 0.350 |
Why?
| | Fibroma, Ossifying | 3 | 2001 | 3 | 0.350 |
Why?
| | Tooth Eruption | 5 | 2014 | 8 | 0.350 |
Why?
| | Pharyngeal Diseases | 1 | 2009 | 12 | 0.350 |
Why?
| | Palatine Tonsil | 1 | 2009 | 32 | 0.350 |
Why?
| | Schools, Dental | 2 | 2011 | 16 | 0.350 |
Why?
| | Microscopy, Polarization | 15 | 2013 | 30 | 0.340 |
Why?
| | Academic Medical Centers | 2 | 2011 | 414 | 0.330 |
Why?
| | Teaching | 1 | 2011 | 224 | 0.330 |
Why?
| | Adult | 52 | 2013 | 30718 | 0.330 |
Why?
| | Cysts | 3 | 2002 | 93 | 0.330 |
Why?
| | Middle Aged | 41 | 2013 | 26999 | 0.330 |
Why?
| | Glossitis, Benign Migratory | 3 | 2010 | 5 | 0.320 |
Why?
| | Anesthesia, Dental | 5 | 2014 | 16 | 0.310 |
Why?
| | Alveolar Bone Loss | 2 | 2007 | 10 | 0.310 |
Why?
| | Immunocompromised Host | 6 | 2013 | 197 | 0.310 |
Why?
| | Stomatitis, Herpetic | 4 | 2001 | 5 | 0.310 |
Why?
| | Acyclovir | 6 | 2004 | 100 | 0.300 |
Why?
| | Salivary Gland Calculi | 2 | 2000 | 3 | 0.300 |
Why?
| | Dental Care for Chronically Ill | 5 | 2006 | 11 | 0.300 |
Why?
| | Dental Materials | 3 | 2003 | 52 | 0.300 |
Why?
| | Tooth Demineralization | 8 | 2013 | 10 | 0.300 |
Why?
| | Papillomavirus Infections | 3 | 2013 | 258 | 0.300 |
Why?
| | Acquired Immunodeficiency Syndrome | 4 | 2001 | 221 | 0.290 |
Why?
| | Learning | 1 | 2011 | 358 | 0.290 |
Why?
| | Incisor | 4 | 2002 | 16 | 0.290 |
Why?
| | Denture, Complete, Lower | 1 | 2007 | 1 | 0.290 |
Why?
| | Dental Implantation, Endosseous | 1 | 2007 | 2 | 0.290 |
Why?
| | Dental Prosthesis, Implant-Supported | 1 | 2007 | 4 | 0.290 |
Why?
| | Maxillary Neoplasms | 4 | 1995 | 7 | 0.280 |
Why?
| | Dental Implants | 1 | 2007 | 9 | 0.280 |
Why?
| | Gingival Overgrowth | 3 | 2003 | 5 | 0.280 |
Why?
| | Head and Neck Neoplasms | 3 | 2002 | 425 | 0.280 |
Why?
| | Valine | 5 | 2004 | 74 | 0.280 |
Why?
| | Tooth, Unerupted | 2 | 2002 | 2 | 0.270 |
Why?
| | Texas | 8 | 2017 | 187 | 0.270 |
Why?
| | Tooth, Impacted | 3 | 2003 | 9 | 0.270 |
Why?
| | Epstein-Barr Virus Infections | 5 | 2007 | 71 | 0.270 |
Why?
| | Dental Enamel Solubility | 5 | 2006 | 5 | 0.270 |
Why?
| | Maxilla | 7 | 2002 | 29 | 0.270 |
Why?
| | Epithelium | 8 | 2012 | 297 | 0.260 |
Why?
| | Sarcoidosis | 1 | 2007 | 134 | 0.260 |
Why?
| | Mouth Floor | 3 | 2000 | 6 | 0.260 |
Why?
| | Molluscum Contagiosum | 2 | 2002 | 2 | 0.260 |
Why?
| | Lasers | 6 | 2004 | 121 | 0.250 |
Why?
| | Tuberculosis, Lymph Node | 1 | 2005 | 5 | 0.250 |
Why?
| | Dental Research | 1 | 2005 | 7 | 0.250 |
Why?
| | Histiocytosis, Langerhans-Cell | 1 | 2005 | 35 | 0.250 |
Why?
| | Odontoma | 2 | 2003 | 4 | 0.250 |
Why?
| | Cytodiagnosis | 4 | 2012 | 28 | 0.250 |
Why?
| | Cuspid | 2 | 2002 | 10 | 0.250 |
Why?
| | Acid Etching, Dental | 6 | 2001 | 14 | 0.240 |
Why?
| | Dentist-Patient Relations | 3 | 2013 | 5 | 0.240 |
Why?
| | Microscopy, Electron, Scanning | 15 | 2003 | 194 | 0.240 |
Why?
| | Tooth Root | 9 | 2013 | 14 | 0.240 |
Why?
| | Lymphocele | 1 | 2004 | 2 | 0.240 |
Why?
| | Compomers | 2 | 2003 | 2 | 0.240 |
Why?
| | Tongue Diseases | 1 | 2004 | 8 | 0.240 |
Why?
| | Calcium | 5 | 2007 | 1103 | 0.230 |
Why?
| | Calcium Phosphates | 2 | 2004 | 25 | 0.230 |
Why?
| | Prognosis | 12 | 2002 | 3339 | 0.230 |
Why?
| | Warts | 2 | 2001 | 4 | 0.230 |
Why?
| | Glass Ionomer Cements | 5 | 2003 | 9 | 0.230 |
Why?
| | Biopsy | 7 | 2012 | 1056 | 0.230 |
Why?
| | Root Resorption | 3 | 2006 | 4 | 0.230 |
Why?
| | Lymphoma, AIDS-Related | 2 | 2002 | 13 | 0.230 |
Why?
| | Adolescent | 30 | 2014 | 17889 | 0.230 |
Why?
| | Dentists | 2 | 2001 | 19 | 0.230 |
Why?
| | Granuloma, Giant Cell | 2 | 2000 | 4 | 0.220 |
Why?
| | Erythema | 2 | 2001 | 25 | 0.220 |
Why?
| | Bites, Human | 2 | 2014 | 3 | 0.220 |
Why?
| | Dental Amalgam | 1 | 2002 | 2 | 0.220 |
Why?
| | Cytomegalovirus Infections | 2 | 1996 | 182 | 0.210 |
Why?
| | Universities | 1 | 2005 | 340 | 0.210 |
Why?
| | Dental Caries Susceptibility | 10 | 2006 | 12 | 0.210 |
Why?
| | Cyclosporine | 1 | 2003 | 169 | 0.210 |
Why?
| | Parotitis | 2 | 2003 | 6 | 0.200 |
Why?
| | Crowns | 1 | 2002 | 2 | 0.200 |
Why?
| | Personal Autonomy | 2 | 2013 | 39 | 0.200 |
Why?
| | Cheilitis | 2 | 2003 | 3 | 0.200 |
Why?
| | Toothpastes | 2 | 2000 | 5 | 0.200 |
Why?
| | Sialadenitis | 1 | 2001 | 1 | 0.200 |
Why?
| | Sublingual Gland | 1 | 2001 | 1 | 0.200 |
Why?
| | Rhabdomyosarcoma | 1 | 2002 | 52 | 0.200 |
Why?
| | Salivary Glands, Minor | 2 | 2000 | 8 | 0.200 |
Why?
| | Diazepam | 3 | 1986 | 27 | 0.200 |
Why?
| | Blister | 1 | 2001 | 43 | 0.200 |
Why?
| | Immunosuppressive Agents | 2 | 2003 | 666 | 0.190 |
Why?
| | Evidence-Based Dentistry | 2 | 2012 | 7 | 0.190 |
Why?
| | Pediatric Dentistry | 3 | 2001 | 9 | 0.190 |
Why?
| | Fibroma | 1 | 2001 | 21 | 0.190 |
Why?
| | Antiretroviral Therapy, Highly Active | 3 | 2013 | 257 | 0.190 |
Why?
| | Durapatite | 2 | 2004 | 32 | 0.190 |
Why?
| | Hair Dyes | 1 | 2000 | 2 | 0.190 |
Why?
| | Burkitt Lymphoma | 1 | 2001 | 52 | 0.190 |
Why?
| | Lip | 2 | 2000 | 20 | 0.190 |
Why?
| | Candida | 4 | 2006 | 35 | 0.190 |
Why?
| | Sjogren's Syndrome | 1 | 2001 | 42 | 0.180 |
Why?
| | Malpractice | 1 | 2001 | 37 | 0.180 |
Why?
| | Neoplasms, Second Primary | 1 | 2002 | 91 | 0.180 |
Why?
| | Palate, Hard | 1 | 2000 | 4 | 0.180 |
Why?
| | Dental Care for Children | 2 | 1999 | 13 | 0.180 |
Why?
| | Disease Progression | 5 | 2013 | 2418 | 0.180 |
Why?
| | Palatal Neoplasms | 1 | 2000 | 4 | 0.180 |
Why?
| | Neuroma | 1 | 2000 | 11 | 0.180 |
Why?
| | Saliva, Artificial | 7 | 2014 | 10 | 0.180 |
Why?
| | Argon | 15 | 2004 | 20 | 0.180 |
Why?
| | Focal Epithelial Hyperplasia | 1 | 2000 | 1 | 0.180 |
Why?
| | Lymphangioma | 1 | 2000 | 7 | 0.180 |
Why?
| | Virus Replication | 6 | 2007 | 396 | 0.180 |
Why?
| | Biomarkers, Tumor | 4 | 2004 | 1048 | 0.180 |
Why?
| | Neoplasms, Glandular and Epithelial | 1 | 2000 | 39 | 0.180 |
Why?
| | Lipoma | 1 | 2000 | 16 | 0.180 |
Why?
| | Hyperplasia | 4 | 2003 | 166 | 0.180 |
Why?
| | Child Behavior | 3 | 2014 | 218 | 0.170 |
Why?
| | Calcinosis | 1 | 2002 | 242 | 0.170 |
Why?
| | Herpesvirus 8, Human | 2 | 1997 | 63 | 0.170 |
Why?
| | Mineral Waters | 2 | 1989 | 2 | 0.170 |
Why?
| | Mandible | 5 | 2007 | 62 | 0.170 |
Why?
| | Candidiasis | 1 | 1999 | 58 | 0.160 |
Why?
| | Self-Injurious Behavior | 1 | 2000 | 114 | 0.160 |
Why?
| | Hydrogen-Ion Concentration | 5 | 2014 | 515 | 0.160 |
Why?
| | Oncogenic Viruses | 1 | 1998 | 3 | 0.160 |
Why?
| | Vinblastine | 3 | 1995 | 61 | 0.160 |
Why?
| | Attitude to Health | 2 | 2013 | 409 | 0.160 |
Why?
| | Facial Dermatoses | 3 | 2008 | 14 | 0.160 |
Why?
| | Light | 5 | 2012 | 337 | 0.160 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2013 | 1216 | 0.160 |
Why?
| | Statistics, Nonparametric | 7 | 2007 | 390 | 0.160 |
Why?
| | Dens in Dente | 2 | 1990 | 2 | 0.160 |
Why?
| | Osteoradionecrosis | 1 | 1998 | 2 | 0.150 |
Why?
| | Nose Diseases | 1 | 1998 | 11 | 0.150 |
Why?
| | Pulpotomy | 2 | 1989 | 2 | 0.150 |
Why?
| | Neoplasm Recurrence, Local | 6 | 2011 | 863 | 0.150 |
Why?
| | Palate | 1 | 1998 | 27 | 0.150 |
Why?
| | Myxoma | 1 | 1997 | 11 | 0.150 |
Why?
| | X-Ray Film | 2 | 1987 | 5 | 0.150 |
Why?
| | Cleft Lip | 1 | 2017 | 31 | 0.150 |
Why?
| | Food Hypersensitivity | 1 | 2001 | 254 | 0.150 |
Why?
| | Specimen Handling | 1 | 1998 | 156 | 0.150 |
Why?
| | Periodontal Diseases | 3 | 2007 | 54 | 0.140 |
Why?
| | Cleft Palate | 1 | 2017 | 45 | 0.140 |
Why?
| | Leukoplakia, Oral | 2 | 2011 | 6 | 0.140 |
Why?
| | Cooperative Behavior | 4 | 2011 | 390 | 0.140 |
Why?
| | Taste Buds | 1 | 1999 | 209 | 0.140 |
Why?
| | Xylitol | 2 | 2014 | 3 | 0.140 |
Why?
| | Melanoma | 2 | 2000 | 651 | 0.140 |
Why?
| | Tooth Bleaching | 1 | 1996 | 3 | 0.140 |
Why?
| | Peroxides | 1 | 1996 | 20 | 0.140 |
Why?
| | Chronic Disease | 2 | 2018 | 1598 | 0.140 |
Why?
| | Ameloblastoma | 2 | 1993 | 5 | 0.140 |
Why?
| | Acids | 2 | 2012 | 17 | 0.130 |
Why?
| | Ulcer | 1 | 1996 | 28 | 0.130 |
Why?
| | Urea | 1 | 1996 | 69 | 0.130 |
Why?
| | Anesthesia, Rectal | 2 | 1985 | 2 | 0.130 |
Why?
| | Langerhans Cells | 2 | 2007 | 11 | 0.130 |
Why?
| | HIV Seronegativity | 4 | 2007 | 24 | 0.130 |
Why?
| | Osteomyelitis | 2 | 2000 | 103 | 0.130 |
Why?
| | Jaw Neoplasms | 1 | 1995 | 2 | 0.130 |
Why?
| | Sex Factors | 4 | 2016 | 1736 | 0.130 |
Why?
| | Hemangioendothelioma, Epithelioid | 1 | 1995 | 5 | 0.130 |
Why?
| | Age Factors | 6 | 2016 | 2907 | 0.130 |
Why?
| | Acculturation | 1 | 2016 | 52 | 0.130 |
Why?
| | Dental Cavity Preparation | 5 | 2003 | 6 | 0.120 |
Why?
| | Orthodontic Brackets | 3 | 2010 | 13 | 0.120 |
Why?
| | Recurrence | 5 | 2003 | 952 | 0.120 |
Why?
| | Risk Factors | 10 | 2018 | 8697 | 0.120 |
Why?
| | Phosphates | 4 | 2013 | 160 | 0.120 |
Why?
| | Tooth Eruption, Ectopic | 2 | 2003 | 2 | 0.120 |
Why?
| | Gingival Hemorrhage | 1 | 2014 | 3 | 0.120 |
Why?
| | Hernia | 1 | 2014 | 8 | 0.120 |
Why?
| | Mass Screening | 2 | 2012 | 1024 | 0.120 |
Why?
| | Apatites | 2 | 2004 | 4 | 0.120 |
Why?
| | Bisphenol A-Glycidyl Methacrylate | 3 | 2000 | 51 | 0.120 |
Why?
| | Surface Properties | 7 | 2003 | 397 | 0.120 |
Why?
| | Epithelial Cells | 4 | 2007 | 961 | 0.120 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 1995 | 181 | 0.120 |
Why?
| | Diastema | 1 | 1993 | 3 | 0.110 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2011 | 314 | 0.110 |
Why?
| | Fat Necrosis | 1 | 1993 | 7 | 0.110 |
Why?
| | Conscious Sedation | 1 | 2014 | 79 | 0.110 |
Why?
| | Tooth Abnormalities | 2 | 2001 | 12 | 0.110 |
Why?
| | Papillomaviridae | 3 | 2000 | 100 | 0.110 |
Why?
| | Hypercalcemia | 1 | 1993 | 21 | 0.110 |
Why?
| | Infant | 10 | 2002 | 7979 | 0.110 |
Why?
| | Chromosome Aberrations | 2 | 2005 | 134 | 0.110 |
Why?
| | Hypnotics and Sedatives | 1 | 2014 | 134 | 0.110 |
Why?
| | Aurothioglucose | 1 | 1993 | 6 | 0.110 |
Why?
| | Lichen Planus | 1 | 1993 | 3 | 0.110 |
Why?
| | Antiviral Agents | 6 | 2004 | 651 | 0.110 |
Why?
| | Human papillomavirus 16 | 1 | 2013 | 25 | 0.110 |
Why?
| | Low-Level Light Therapy | 2 | 2004 | 2 | 0.110 |
Why?
| | Curriculum | 2 | 2011 | 852 | 0.110 |
Why?
| | Acrylic Resins | 3 | 2007 | 38 | 0.100 |
Why?
| | Wound Healing | 2 | 2005 | 257 | 0.100 |
Why?
| | DMF Index | 5 | 2003 | 20 | 0.100 |
Why?
| | Cariogenic Agents | 2 | 2014 | 2 | 0.100 |
Why?
| | Tooth Erosion | 1 | 2012 | 3 | 0.100 |
Why?
| | Candy | 1 | 2012 | 4 | 0.100 |
Why?
| | Adolescent Behavior | 2 | 2002 | 480 | 0.100 |
Why?
| | Dentin | 5 | 2001 | 22 | 0.100 |
Why?
| | Moral Development | 1 | 2011 | 2 | 0.100 |
Why?
| | Schools, Health Occupations | 1 | 2011 | 7 | 0.100 |
Why?
| | Simplexvirus | 3 | 1998 | 82 | 0.100 |
Why?
| | Dental Hygienists | 1 | 2011 | 15 | 0.100 |
Why?
| | Keratins | 1 | 2012 | 176 | 0.100 |
Why?
| | Administrative Personnel | 1 | 2011 | 31 | 0.100 |
Why?
| | Staff Development | 1 | 2011 | 40 | 0.100 |
Why?
| | Quality of Life | 2 | 2013 | 2385 | 0.100 |
Why?
| | Bioethical Issues | 1 | 2011 | 8 | 0.100 |
Why?
| | Organizational Objectives | 1 | 2011 | 71 | 0.100 |
Why?
| | Dental Cavity Lining | 2 | 2002 | 2 | 0.100 |
Why?
| | General Practice, Dental | 3 | 2006 | 5 | 0.100 |
Why?
| | Dental Alloys | 3 | 2002 | 5 | 0.090 |
Why?
| | Truth Disclosure | 1 | 2011 | 39 | 0.090 |
Why?
| | Secondary Prevention | 2 | 2002 | 223 | 0.090 |
Why?
| | Alphapapillomavirus | 1 | 2011 | 36 | 0.090 |
Why?
| | Dentin-Bonding Agents | 3 | 2003 | 15 | 0.090 |
Why?
| | Stomatitis, Aphthous | 2 | 2001 | 10 | 0.090 |
Why?
| | Professional Competence | 1 | 2011 | 86 | 0.090 |
Why?
| | Problem-Based Learning | 1 | 2011 | 77 | 0.090 |
Why?
| | DNA, Viral | 5 | 2004 | 351 | 0.090 |
Why?
| | HIV-1 | 1 | 1996 | 771 | 0.090 |
Why?
| | Medical History Taking | 1 | 1991 | 114 | 0.090 |
Why?
| | Polyvinyls | 2 | 2007 | 17 | 0.090 |
Why?
| | Organizational Innovation | 1 | 2011 | 132 | 0.090 |
Why?
| | Orthodontic Appliances | 2 | 2001 | 10 | 0.090 |
Why?
| | Faculty | 1 | 2011 | 131 | 0.090 |
Why?
| | Formocresols | 2 | 1989 | 2 | 0.090 |
Why?
| | Aged | 12 | 2012 | 19251 | 0.090 |
Why?
| | Parents | 2 | 2016 | 1205 | 0.090 |
Why?
| | Gingival Recession | 2 | 2007 | 6 | 0.090 |
Why?
| | Choice Behavior | 1 | 2011 | 159 | 0.090 |
Why?
| | Collagen | 1 | 2012 | 415 | 0.090 |
Why?
| | Periapical Diseases | 1 | 1989 | 1 | 0.080 |
Why?
| | Pulpectomy | 1 | 1989 | 1 | 0.080 |
Why?
| | Dental Clinics | 2 | 2001 | 4 | 0.080 |
Why?
| | Infant, Newborn | 7 | 2002 | 5077 | 0.080 |
Why?
| | Statistics as Topic | 4 | 2001 | 299 | 0.080 |
Why?
| | Program Development | 1 | 2011 | 350 | 0.080 |
Why?
| | Tin Fluorides | 2 | 1988 | 3 | 0.080 |
Why?
| | Cell Division | 3 | 2000 | 759 | 0.080 |
Why?
| | Water Supply | 1 | 1989 | 71 | 0.080 |
Why?
| | Proliferating Cell Nuclear Antigen | 2 | 2000 | 49 | 0.080 |
Why?
| | Vaccination | 1 | 1996 | 1209 | 0.080 |
Why?
| | Drug Combinations | 2 | 2001 | 289 | 0.080 |
Why?
| | Hamartoma | 1 | 2008 | 21 | 0.080 |
Why?
| | Nevus | 1 | 2008 | 26 | 0.080 |
Why?
| | Photomicrography | 2 | 2000 | 7 | 0.080 |
Why?
| | CD4 Lymphocyte Count | 4 | 2006 | 257 | 0.080 |
Why?
| | Porosity | 3 | 2003 | 93 | 0.080 |
Why?
| | Follow-Up Studies | 5 | 2014 | 4440 | 0.070 |
Why?
| | Xerostomia | 3 | 2000 | 19 | 0.070 |
Why?
| | Radicular Cyst | 2 | 1998 | 2 | 0.070 |
Why?
| | In Vitro Techniques | 5 | 2002 | 1044 | 0.070 |
Why?
| | Prevalence | 6 | 2001 | 2264 | 0.070 |
Why?
| | Dental Restoration Failure | 2 | 2006 | 5 | 0.070 |
Why?
| | Denture, Overlay | 1 | 2007 | 5 | 0.070 |
Why?
| | Viral Matrix Proteins | 3 | 2004 | 24 | 0.070 |
Why?
| | Jaw, Edentulous | 1 | 2007 | 5 | 0.070 |
Why?
| | Prospective Studies | 6 | 2014 | 6264 | 0.070 |
Why?
| | Dermatitis, Allergic Contact | 2 | 2000 | 63 | 0.070 |
Why?
| | Denture Bases | 1 | 2006 | 3 | 0.070 |
Why?
| | Denture, Complete, Upper | 1 | 2006 | 3 | 0.070 |
Why?
| | Bone Marrow Transplantation | 1 | 1988 | 239 | 0.070 |
Why?
| | Chromium Alloys | 1 | 2006 | 5 | 0.070 |
Why?
| | Osseointegration | 1 | 2007 | 37 | 0.070 |
Why?
| | Tooth Mobility | 2 | 2006 | 5 | 0.070 |
Why?
| | Dental Prophylaxis | 2 | 2003 | 6 | 0.070 |
Why?
| | HIV | 3 | 1998 | 209 | 0.070 |
Why?
| | Dental Cements | 2 | 2002 | 20 | 0.070 |
Why?
| | Practice Patterns, Dentists' | 1 | 2006 | 3 | 0.070 |
Why?
| | Patient Education as Topic | 1 | 2011 | 686 | 0.070 |
Why?
| | Root Canal Therapy | 1 | 2006 | 5 | 0.070 |
Why?
| | Thermodynamics | 4 | 2001 | 388 | 0.070 |
Why?
| | Root Canal Irrigants | 1 | 1986 | 3 | 0.070 |
Why?
| | Insurance Claim Reporting | 1 | 2006 | 22 | 0.070 |
Why?
| | Neoplasm Staging | 4 | 2010 | 1178 | 0.070 |
Why?
| | Silicon | 1 | 2005 | 14 | 0.070 |
Why?
| | Education, Dental | 1 | 2006 | 21 | 0.070 |
Why?
| | Treatment Outcome | 6 | 2007 | 9159 | 0.070 |
Why?
| | Case-Control Studies | 2 | 2017 | 3022 | 0.070 |
Why?
| | Implants, Experimental | 1 | 2005 | 19 | 0.060 |
Why?
| | Glass | 1 | 2005 | 43 | 0.060 |
Why?
| | Chromosomes, Human, Pair 7 | 1 | 2005 | 15 | 0.060 |
Why?
| | Resins, Plant | 2 | 2002 | 3 | 0.060 |
Why?
| | Infectious Disease Transmission, Vertical | 4 | 2000 | 152 | 0.060 |
Why?
| | Regression Analysis | 2 | 2000 | 959 | 0.060 |
Why?
| | Denture Design | 2 | 2006 | 3 | 0.060 |
Why?
| | Antigens, CD1 | 1 | 2005 | 57 | 0.060 |
Why?
| | Biomedical and Dental Materials | 1 | 2005 | 1 | 0.060 |
Why?
| | Denture, Complete | 1 | 2005 | 4 | 0.060 |
Why?
| | Molar, Third | 1 | 1985 | 10 | 0.060 |
Why?
| | Cytoplasmic Granules | 1 | 2005 | 82 | 0.060 |
Why?
| | Pathology, Oral | 1 | 2005 | 1 | 0.060 |
Why?
| | Antifungal Agents | 3 | 2005 | 133 | 0.060 |
Why?
| | Ganciclovir | 2 | 1996 | 49 | 0.060 |
Why?
| | Retrospective Studies | 8 | 2017 | 12608 | 0.060 |
Why?
| | Romania | 2 | 2003 | 10 | 0.060 |
Why?
| | Malocclusion | 2 | 2001 | 23 | 0.060 |
Why?
| | Chemokines, CC | 1 | 2004 | 28 | 0.060 |
Why?
| | Dental Cementum | 2 | 1995 | 4 | 0.060 |
Why?
| | Phosphoric Acids | 4 | 2001 | 16 | 0.060 |
Why?
| | Receptors, CCR5 | 1 | 2004 | 54 | 0.060 |
Why?
| | Vocabulary, Controlled | 1 | 2005 | 41 | 0.060 |
Why?
| | Epstein-Barr Virus Nuclear Antigens | 1 | 2004 | 8 | 0.060 |
Why?
| | Mental Recall | 1 | 1986 | 173 | 0.060 |
Why?
| | Osteosarcoma | 2 | 1998 | 66 | 0.060 |
Why?
| | Burning Mouth Syndrome | 2 | 1996 | 5 | 0.060 |
Why?
| | Neoplasm Invasiveness | 3 | 2000 | 445 | 0.060 |
Why?
| | Dental Enamel Permeability | 1 | 2004 | 1 | 0.060 |
Why?
| | Memory | 1 | 1986 | 211 | 0.060 |
Why?
| | Halitosis | 1 | 2003 | 1 | 0.060 |
Why?
| | History, 20th Century | 1 | 2005 | 273 | 0.060 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2004 | 80 | 0.060 |
Why?
| | Keratosis | 1 | 2003 | 13 | 0.060 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2004 | 691 | 0.060 |
Why?
| | Lymphoma, B-Cell | 1 | 2004 | 86 | 0.060 |
Why?
| | Sex Distribution | 2 | 2002 | 337 | 0.060 |
Why?
| | Fatal Outcome | 2 | 2002 | 286 | 0.060 |
Why?
| | Connexins | 1 | 2003 | 50 | 0.050 |
Why?
| | Lactobacillus | 1 | 2003 | 24 | 0.050 |
Why?
| | Streptococcus mutans | 1 | 2003 | 8 | 0.050 |
Why?
| | Diet, Cariogenic | 1 | 2003 | 1 | 0.050 |
Why?
| | Immunohistochemistry | 4 | 2003 | 1642 | 0.050 |
Why?
| | Mentors | 1 | 2005 | 162 | 0.050 |
Why?
| | Secretory Rate | 1 | 2003 | 16 | 0.050 |
Why?
| | Stress, Psychological | 1 | 2011 | 974 | 0.050 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2003 | 58 | 0.050 |
Why?
| | Dental Leakage | 1 | 2002 | 3 | 0.050 |
Why?
| | Materials Testing | 4 | 2013 | 356 | 0.050 |
Why?
| | Methacrylates | 2 | 2000 | 110 | 0.050 |
Why?
| | Drug Resistance, Viral | 1 | 2003 | 99 | 0.050 |
Why?
| | Polymerase Chain Reaction | 4 | 2003 | 1000 | 0.050 |
Why?
| | Tooth Injuries | 2 | 2018 | 4 | 0.050 |
Why?
| | Mouthwashes | 3 | 2010 | 12 | 0.050 |
Why?
| | Stem Cells | 1 | 2007 | 546 | 0.050 |
Why?
| | Remission Induction | 1 | 2003 | 240 | 0.050 |
Why?
| | Decision Trees | 1 | 2002 | 81 | 0.050 |
Why?
| | Gold Alloys | 1 | 2002 | 1 | 0.050 |
Why?
| | Combined Modality Therapy | 4 | 2004 | 1127 | 0.050 |
Why?
| | Skin Diseases | 1 | 2003 | 124 | 0.050 |
Why?
| | Cleidocranial Dysplasia | 1 | 2001 | 1 | 0.050 |
Why?
| | Cosmetic Techniques | 1 | 2002 | 11 | 0.050 |
Why?
| | Sclerosis | 1 | 2001 | 11 | 0.050 |
Why?
| | Mycobacterium tuberculosis | 1 | 2005 | 271 | 0.050 |
Why?
| | Diet | 1 | 1989 | 1072 | 0.050 |
Why?
| | Dental Service, Hospital | 1 | 2001 | 1 | 0.050 |
Why?
| | Respiratory System Abnormalities | 1 | 2001 | 13 | 0.050 |
Why?
| | Alcohol Drinking | 4 | 2012 | 648 | 0.050 |
Why?
| | Heart | 1 | 1985 | 608 | 0.050 |
Why?
| | Lactic Acid | 2 | 2014 | 275 | 0.050 |
Why?
| | Biocompatible Materials | 1 | 2005 | 378 | 0.050 |
Why?
| | Mutation, Missense | 1 | 2003 | 296 | 0.050 |
Why?
| | Dental Pulp Necrosis | 1 | 2001 | 1 | 0.050 |
Why?
| | Pericoronitis | 1 | 2001 | 1 | 0.050 |
Why?
| | Caustics | 1 | 2001 | 7 | 0.050 |
Why?
| | Hypoparathyroidism | 1 | 1981 | 4 | 0.050 |
Why?
| | 2-Propanol | 1 | 2001 | 21 | 0.050 |
Why?
| | Dental Enamel Hypoplasia | 1 | 1981 | 6 | 0.050 |
Why?
| | Time Factors | 8 | 2014 | 6165 | 0.050 |
Why?
| | Fishes | 1 | 2001 | 81 | 0.050 |
Why?
| | Zirconium | 1 | 2001 | 4 | 0.050 |
Why?
| | Anti-Infective Agents, Local | 1 | 2001 | 39 | 0.050 |
Why?
| | Bicuspid | 3 | 2000 | 11 | 0.050 |
Why?
| | Salivary Gland Diseases | 1 | 2001 | 2 | 0.050 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 1989 | 1198 | 0.050 |
Why?
| | AIDS Serodiagnosis | 1 | 2001 | 29 | 0.050 |
Why?
| | Mandibular Nerve | 1 | 2000 | 6 | 0.050 |
Why?
| | Folliculitis | 1 | 2000 | 1 | 0.050 |
Why?
| | Tooth Crown | 1 | 2000 | 2 | 0.050 |
Why?
| | Plasminogen | 1 | 2001 | 32 | 0.050 |
Why?
| | Silicates | 1 | 2000 | 11 | 0.050 |
Why?
| | Liability, Legal | 1 | 2001 | 38 | 0.050 |
Why?
| | Phenols | 1 | 2001 | 82 | 0.050 |
Why?
| | Arthritis, Juvenile | 1 | 2001 | 42 | 0.050 |
Why?
| | Denture, Partial, Removable | 1 | 2000 | 3 | 0.050 |
Why?
| | Habits | 1 | 2000 | 37 | 0.050 |
Why?
| | Nickel | 2 | 2006 | 52 | 0.050 |
Why?
| | Periodontitis | 1 | 2001 | 42 | 0.050 |
Why?
| | Emergencies | 1 | 2001 | 147 | 0.050 |
Why?
| | Granuloma, Pyogenic | 1 | 2000 | 6 | 0.050 |
Why?
| | Polymethacrylic Acids | 1 | 2000 | 61 | 0.040 |
Why?
| | Hyperpigmentation | 1 | 2000 | 11 | 0.040 |
Why?
| | Hair | 1 | 2000 | 66 | 0.040 |
Why?
| | Diffusion | 1 | 2000 | 120 | 0.040 |
Why?
| | Silicic Acid | 1 | 2000 | 2 | 0.040 |
Why?
| | Ki-67 Antigen | 1 | 2000 | 104 | 0.040 |
Why?
| | Coloring Agents | 3 | 2012 | 71 | 0.040 |
Why?
| | Survival Rate | 2 | 2002 | 1650 | 0.040 |
Why?
| | Smoking | 4 | 2012 | 1457 | 0.040 |
Why?
| | Complex Mixtures | 1 | 2000 | 12 | 0.040 |
Why?
| | Triclosan | 1 | 2000 | 9 | 0.040 |
Why?
| | Silicon Dioxide | 1 | 2001 | 94 | 0.040 |
Why?
| | Age Distribution | 3 | 2001 | 341 | 0.040 |
Why?
| | DNA, Neoplasm | 3 | 1995 | 157 | 0.040 |
Why?
| | Cytomegalovirus | 2 | 1998 | 146 | 0.040 |
Why?
| | Nerve Block | 1 | 2000 | 62 | 0.040 |
Why?
| | Hydrogen Peroxide | 1 | 2001 | 287 | 0.040 |
Why?
| | Mucocele | 1 | 1999 | 11 | 0.040 |
Why?
| | Models, Biological | 1 | 2007 | 1646 | 0.040 |
Why?
| | American Dental Association | 2 | 2012 | 6 | 0.040 |
Why?
| | Graft Rejection | 1 | 2003 | 533 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2007 | 1700 | 0.040 |
Why?
| | Foreign Bodies | 1 | 2000 | 99 | 0.040 |
Why?
| | Renal Dialysis | 1 | 2003 | 369 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2002 | 385 | 0.040 |
Why?
| | Flavonoids | 1 | 1999 | 68 | 0.040 |
Why?
| | Sequence Analysis, DNA | 2 | 2004 | 732 | 0.040 |
Why?
| | Plasminogen Activators | 1 | 1998 | 7 | 0.040 |
Why?
| | Collagenases | 1 | 1998 | 22 | 0.040 |
Why?
| | Herpesviridae | 1 | 1998 | 21 | 0.040 |
Why?
| | Vacuum | 1 | 1998 | 14 | 0.040 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 171 | 0.040 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 1998 | 28 | 0.040 |
Why?
| | Injections, Intralesional | 2 | 1995 | 32 | 0.040 |
Why?
| | Gram-Negative Anaerobic Cocci | 1 | 1998 | 1 | 0.040 |
Why?
| | Virus Shedding | 1 | 1998 | 39 | 0.040 |
Why?
| | Evaluation Studies as Topic | 2 | 1989 | 169 | 0.040 |
Why?
| | Suction | 1 | 1998 | 31 | 0.040 |
Why?
| | Equipment Design | 1 | 2000 | 517 | 0.040 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 1998 | 37 | 0.040 |
Why?
| | Arteries | 1 | 2000 | 250 | 0.040 |
Why?
| | Bone Cysts | 1 | 1998 | 11 | 0.040 |
Why?
| | Recombination, Genetic | 1 | 1999 | 177 | 0.040 |
Why?
| | Fibrosarcoma | 1 | 1998 | 20 | 0.040 |
Why?
| | Periodontal Cyst | 1 | 1997 | 1 | 0.040 |
Why?
| | Eosinophilic Granuloma | 1 | 1997 | 3 | 0.040 |
Why?
| | Incidence | 2 | 2012 | 2335 | 0.040 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 1999 | 277 | 0.040 |
Why?
| | Temperature | 1 | 2000 | 587 | 0.040 |
Why?
| | Motor Skills | 1 | 1998 | 80 | 0.040 |
Why?
| | Nose | 1 | 1998 | 56 | 0.040 |
Why?
| | Oropharyngeal Neoplasms | 1 | 1998 | 39 | 0.040 |
Why?
| | Cytokines | 1 | 2005 | 1853 | 0.040 |
Why?
| | United States | 5 | 2012 | 12295 | 0.040 |
Why?
| | Hemangioma | 1 | 1997 | 41 | 0.040 |
Why?
| | Adrenal Cortex Hormones | 1 | 2001 | 509 | 0.040 |
Why?
| | Early Detection of Cancer | 2 | 2012 | 340 | 0.040 |
Why?
| | Colony Count, Microbial | 3 | 2006 | 112 | 0.040 |
Why?
| | Survival Analysis | 1 | 2000 | 1219 | 0.040 |
Why?
| | Gels | 2 | 2014 | 72 | 0.040 |
Why?
| | Anti-HIV Agents | 2 | 2000 | 669 | 0.040 |
Why?
| | Viral Proteins | 3 | 2004 | 286 | 0.040 |
Why?
| | Periapical Granuloma | 1 | 1996 | 1 | 0.040 |
Why?
| | Kidney Transplantation | 1 | 2003 | 558 | 0.040 |
Why?
| | Radiotherapy | 1 | 1998 | 177 | 0.040 |
Why?
| | Cryptococcosis | 1 | 1997 | 23 | 0.040 |
Why?
| | Dental Enamel Proteins | 1 | 1996 | 2 | 0.030 |
Why?
| | Herpes Zoster | 1 | 2001 | 333 | 0.030 |
Why?
| | Molecular Sequence Data | 4 | 2004 | 2790 | 0.030 |
Why?
| | Role | 1 | 1996 | 32 | 0.030 |
Why?
| | Growth Substances | 1 | 1996 | 136 | 0.030 |
Why?
| | Digestive System | 1 | 1996 | 27 | 0.030 |
Why?
| | Cytopathogenic Effect, Viral | 1 | 1996 | 16 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2005 | 1447 | 0.030 |
Why?
| | Referral and Consultation | 1 | 2001 | 646 | 0.030 |
Why?
| | Choristoma | 1 | 1996 | 23 | 0.030 |
Why?
| | Antibiotic Prophylaxis | 1 | 1997 | 96 | 0.030 |
Why?
| | Enzyme Inhibitors | 1 | 1999 | 757 | 0.030 |
Why?
| | Pilot Projects | 3 | 2006 | 1377 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2000 | 6417 | 0.030 |
Why?
| | Patient Care Team | 1 | 2000 | 521 | 0.030 |
Why?
| | Sarcoma, Small Cell | 1 | 1995 | 1 | 0.030 |
Why?
| | Carcinoma, Basosquamous | 1 | 1995 | 2 | 0.030 |
Why?
| | Placebos | 2 | 1986 | 198 | 0.030 |
Why?
| | Carcinoma in Situ | 1 | 1995 | 44 | 0.030 |
Why?
| | Fibroblast Growth Factors | 1 | 1996 | 162 | 0.030 |
Why?
| | Virus Activation | 2 | 2007 | 78 | 0.030 |
Why?
| | Cocarcinogenesis | 1 | 1995 | 14 | 0.030 |
Why?
| | Virus Latency | 2 | 2007 | 80 | 0.030 |
Why?
| | Immunization Schedule | 1 | 1996 | 184 | 0.030 |
Why?
| | Hydroxyzine | 1 | 2014 | 6 | 0.030 |
Why?
| | Meperidine | 1 | 2014 | 4 | 0.030 |
Why?
| | Anesthesia Recovery Period | 1 | 2014 | 9 | 0.030 |
Why?
| | Dyskinesia, Drug-Induced | 1 | 2014 | 11 | 0.030 |
Why?
| | Akathisia, Drug-Induced | 1 | 2014 | 6 | 0.030 |
Why?
| | Salivary Glands | 1 | 1994 | 31 | 0.030 |
Why?
| | Clobetasol | 1 | 1994 | 4 | 0.030 |
Why?
| | Amino Acid Sequence | 3 | 2004 | 2000 | 0.030 |
Why?
| | Lupus Erythematosus, Discoid | 1 | 1994 | 7 | 0.030 |
Why?
| | Midazolam | 1 | 2014 | 43 | 0.030 |
Why?
| | Genes, Viral | 2 | 2004 | 89 | 0.030 |
Why?
| | Sleep Stages | 1 | 2014 | 61 | 0.030 |
Why?
| | Neoplasms, Multiple Primary | 1 | 1995 | 52 | 0.030 |
Why?
| | Emergency Medical Services | 1 | 2001 | 590 | 0.030 |
Why?
| | Sodium Dodecyl Sulfate | 1 | 2014 | 21 | 0.030 |
Why?
| | Adhesiveness | 1 | 1994 | 19 | 0.030 |
Why?
| | Psychomotor Agitation | 1 | 2014 | 66 | 0.030 |
Why?
| | Ketoconazole | 1 | 1993 | 4 | 0.030 |
Why?
| | Salivary Proteins and Peptides | 1 | 1993 | 10 | 0.030 |
Why?
| | Vomiting | 1 | 2014 | 125 | 0.030 |
Why?
| | Awareness | 1 | 2014 | 92 | 0.030 |
Why?
| | Papillon-Lefevre Disease | 1 | 1993 | 1 | 0.030 |
Why?
| | Zidovudine | 1 | 1993 | 77 | 0.030 |
Why?
| | Surface-Active Agents | 1 | 2014 | 79 | 0.030 |
Why?
| | Receptor, ErbB-2 | 1 | 1995 | 302 | 0.030 |
Why?
| | Tooth Loss | 1 | 1993 | 30 | 0.030 |
Why?
| | Tolonium Chloride | 1 | 2012 | 3 | 0.030 |
Why?
| | Bacteria | 1 | 1998 | 729 | 0.030 |
Why?
| | Fibrous Dysplasia of Bone | 1 | 1991 | 5 | 0.030 |
Why?
| | Lymphoma, Large B-Cell, Diffuse | 1 | 1993 | 97 | 0.030 |
Why?
| | Antigens, Neoplasm | 1 | 1993 | 223 | 0.020 |
Why?
| | Asymptomatic Diseases | 1 | 2012 | 77 | 0.020 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 1995 | 449 | 0.020 |
Why?
| | Double-Blind Method | 2 | 1986 | 1660 | 0.020 |
Why?
| | Control Groups | 1 | 2011 | 10 | 0.020 |
Why?
| | Cell Transformation, Viral | 1 | 2011 | 24 | 0.020 |
Why?
| | Dental Marginal Adaptation | 2 | 2003 | 10 | 0.020 |
Why?
| | Triamcinolone Acetonide | 1 | 1991 | 27 | 0.020 |
Why?
| | Antigens, CD | 1 | 1993 | 442 | 0.020 |
Why?
| | Sarcoma, Ewing | 1 | 1991 | 62 | 0.020 |
Why?
| | Physical Examination | 1 | 2012 | 222 | 0.020 |
Why?
| | Animals | 5 | 2005 | 32102 | 0.020 |
Why?
| | RNA, Viral | 2 | 2004 | 565 | 0.020 |
Why?
| | Bias | 1 | 2011 | 179 | 0.020 |
Why?
| | Review Literature as Topic | 1 | 2010 | 73 | 0.020 |
Why?
| | Cell Adhesion | 2 | 2006 | 433 | 0.020 |
Why?
| | Motor Activity | 1 | 2014 | 633 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 1870 | 0.020 |
Why?
| | Zinc Oxide-Eugenol Cement | 1 | 1989 | 1 | 0.020 |
Why?
| | Tooth Extraction | 1 | 1989 | 20 | 0.020 |
Why?
| | Genotype | 2 | 2004 | 1786 | 0.020 |
Why?
| | Sleep | 1 | 2014 | 625 | 0.020 |
Why?
| | Matrix Metalloproteinase 9 | 2 | 1999 | 117 | 0.020 |
Why?
| | Oral Hemorrhage | 2 | 2001 | 2 | 0.020 |
Why?
| | Sweetening Agents | 1 | 1988 | 37 | 0.020 |
Why?
| | Microscopy, Electron | 2 | 1998 | 409 | 0.020 |
Why?
| | Immunoenzyme Techniques | 1 | 1988 | 193 | 0.020 |
Why?
| | Cross-Sectional Studies | 2 | 2011 | 4435 | 0.020 |
Why?
| | Mice, Nude | 2 | 1999 | 639 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1995 | 1361 | 0.020 |
Why?
| | Cohort Studies | 2 | 2011 | 4944 | 0.020 |
Why?
| | Flow Cytometry | 3 | 1995 | 1083 | 0.020 |
Why?
| | Prosthodontics | 1 | 2006 | 1 | 0.020 |
Why?
| | Periodontics | 1 | 2006 | 3 | 0.020 |
Why?
| | Endodontics | 1 | 2006 | 3 | 0.020 |
Why?
| | Dentistry, Operative | 1 | 2006 | 4 | 0.020 |
Why?
| | Dental Fistula | 1 | 2006 | 1 | 0.020 |
Why?
| | Periapical Periodontitis | 1 | 2006 | 2 | 0.020 |
Why?
| | Current Procedural Terminology | 1 | 2006 | 11 | 0.020 |
Why?
| | Suppositories | 1 | 1986 | 3 | 0.020 |
Why?
| | Preanesthetic Medication | 1 | 1986 | 3 | 0.020 |
Why?
| | Fluorescent Dyes | 2 | 1998 | 304 | 0.020 |
Why?
| | Anesthesia, Local | 1 | 1986 | 14 | 0.020 |
Why?
| | Amnesia | 1 | 1986 | 42 | 0.020 |
Why?
| | Pharmaceutical Preparations | 1 | 1988 | 169 | 0.020 |
Why?
| | Lung Neoplasms | 2 | 1995 | 2207 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 1997 | 1724 | 0.020 |
Why?
| | Beryllium | 1 | 2006 | 146 | 0.020 |
Why?
| | Prostatic Neoplasms | 1 | 1992 | 927 | 0.020 |
Why?
| | Drug Carriers | 1 | 2006 | 113 | 0.020 |
Why?
| | Diagnosis, Oral | 1 | 2005 | 7 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2005 | 324 | 0.020 |
Why?
| | Immunoglobulin J-Chains | 1 | 2004 | 7 | 0.020 |
Why?
| | Lighting | 1 | 2004 | 25 | 0.020 |
Why?
| | Genes, Immunoglobulin | 1 | 2004 | 26 | 0.020 |
Why?
| | Wettability | 1 | 2004 | 13 | 0.020 |
Why?
| | Sequence Analysis | 1 | 2004 | 35 | 0.020 |
Why?
| | In Situ Hybridization | 2 | 1996 | 298 | 0.010 |
Why?
| | Practice Guidelines as Topic | 1 | 2012 | 1405 | 0.010 |
Why?
| | Cells, Cultured | 2 | 2007 | 3914 | 0.010 |
Why?
| | Immunoglobulin Heavy Chains | 1 | 2004 | 72 | 0.010 |
Why?
| | Rabbits | 1 | 2005 | 752 | 0.010 |
Why?
| | Molecular Epidemiology | 1 | 2004 | 66 | 0.010 |
Why?
| | Clone Cells | 1 | 2004 | 248 | 0.010 |
Why?
| | Connexin 26 | 1 | 2003 | 8 | 0.010 |
Why?
| | Mouth | 1 | 2004 | 67 | 0.010 |
Why?
| | Sulfur Compounds | 1 | 2003 | 5 | 0.010 |
Why?
| | Dental Plaque Index | 1 | 2003 | 4 | 0.010 |
Why?
| | Asthma | 1 | 1997 | 2066 | 0.010 |
Why?
| | Periodontal Index | 1 | 2003 | 12 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2004 | 327 | 0.010 |
Why?
| | Gene Rearrangement | 1 | 2004 | 135 | 0.010 |
Why?
| | Orthodontic Wires | 1 | 2003 | 5 | 0.010 |
Why?
| | Tooth Movement Techniques | 1 | 2003 | 11 | 0.010 |
Why?
| | Longitudinal Studies | 2 | 2000 | 2416 | 0.010 |
Why?
| | Breath Tests | 1 | 2003 | 83 | 0.010 |
Why?
| | Genetic Markers | 1 | 2004 | 325 | 0.010 |
Why?
| | Cell Count | 1 | 2004 | 305 | 0.010 |
Why?
| | RNA, Messenger | 2 | 2004 | 2574 | 0.010 |
Why?
| | Colorado | 2 | 1990 | 4113 | 0.010 |
Why?
| | Adhesives | 1 | 2003 | 11 | 0.010 |
Why?
| | Lymphocytes | 1 | 2004 | 344 | 0.010 |
Why?
| | Observer Variation | 1 | 2003 | 297 | 0.010 |
Why?
| | Herpes Simplex | 1 | 2003 | 88 | 0.010 |
Why?
| | Cell Movement | 1 | 2007 | 867 | 0.010 |
Why?
| | Stomatitis | 1 | 2002 | 13 | 0.010 |
Why?
| | Pigmentation Disorders | 1 | 2002 | 7 | 0.010 |
Why?
| | Hypertrophy | 1 | 2002 | 110 | 0.010 |
Why?
| | Tooth, Supernumerary | 1 | 2001 | 1 | 0.010 |
Why?
| | Color | 1 | 2002 | 75 | 0.010 |
Why?
| | Musculoskeletal Abnormalities | 1 | 2001 | 10 | 0.010 |
Why?
| | Pigmentation | 1 | 2002 | 55 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2007 | 773 | 0.010 |
Why?
| | Toothache | 1 | 2001 | 5 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 2004 | 501 | 0.010 |
Why?
| | Anti-Retroviral Agents | 1 | 2003 | 207 | 0.010 |
Why?
| | Blood Protein Disorders | 1 | 2001 | 1 | 0.010 |
Why?
| | Erbium | 1 | 2001 | 5 | 0.010 |
Why?
| | Yttrium | 1 | 2001 | 5 | 0.010 |
Why?
| | Aluminum Silicates | 1 | 2001 | 11 | 0.010 |
Why?
| | Washington | 1 | 2001 | 134 | 0.010 |
Why?
| | Flatfoot | 1 | 2001 | 38 | 0.010 |
Why?
| | Hemodynamics | 1 | 1985 | 968 | 0.010 |
Why?
| | Conjunctivitis | 1 | 2001 | 17 | 0.010 |
Why?
| | Dentition, Permanent | 1 | 2000 | 4 | 0.010 |
Why?
| | Mice | 3 | 2004 | 15052 | 0.010 |
Why?
| | Odds Ratio | 1 | 2003 | 962 | 0.010 |
Why?
| | Staining and Labeling | 1 | 2001 | 139 | 0.010 |
Why?
| | Pedigree | 1 | 2001 | 467 | 0.010 |
Why?
| | Acetates | 1 | 2001 | 96 | 0.010 |
Why?
| | Lymphatic Diseases | 1 | 2000 | 17 | 0.010 |
Why?
| | Cesarean Section | 1 | 2001 | 169 | 0.010 |
Why?
| | 1,2-Dipalmitoylphosphatidylcholine | 1 | 1999 | 10 | 0.010 |
Why?
| | Matrix Metalloproteinase Inhibitors | 1 | 1999 | 13 | 0.010 |
Why?
| | Decision Making | 1 | 2006 | 791 | 0.010 |
Why?
| | Trans-Activators | 1 | 2001 | 370 | 0.010 |
Why?
| | Scoliosis | 1 | 2001 | 181 | 0.010 |
Why?
| | Dentin Sensitivity | 1 | 1998 | 2 | 0.010 |
Why?
| | Delayed-Action Preparations | 1 | 2000 | 159 | 0.010 |
Why?
| | Neck Muscles | 1 | 1998 | 11 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 147 | 0.010 |
Why?
| | Hematoxylin | 1 | 1998 | 3 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 1999 | 166 | 0.010 |
Why?
| | Eosine Yellowish-(YS) | 1 | 1998 | 7 | 0.010 |
Why?
| | Methenamine | 1 | 1998 | 4 | 0.010 |
Why?
| | Logistic Models | 1 | 2003 | 1856 | 0.010 |
Why?
| | Hearing Loss | 1 | 2001 | 183 | 0.010 |
Why?
| | Injections, Intramuscular | 1 | 1998 | 118 | 0.010 |
Why?
| | Transcription, Genetic | 1 | 2004 | 1310 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 1998 | 235 | 0.010 |
Why?
| | Point Mutation | 1 | 1999 | 217 | 0.010 |
Why?
| | Paraffin Embedding | 1 | 1998 | 21 | 0.010 |
Why?
| | Drug Resistance, Microbial | 1 | 1998 | 66 | 0.010 |
Why?
| | Random Allocation | 1 | 1998 | 337 | 0.010 |
Why?
| | Mothers | 1 | 2003 | 666 | 0.010 |
Why?
| | Macrophages | 1 | 2004 | 1284 | 0.010 |
Why?
| | Organic Chemicals | 1 | 1998 | 116 | 0.010 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 1998 | 274 | 0.010 |
Why?
| | Pneumonia, Pneumocystis | 1 | 1997 | 27 | 0.010 |
Why?
| | Causalgia | 1 | 1996 | 1 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 1998 | 850 | 0.010 |
Why?
| | Periodontal Ligament | 1 | 1996 | 2 | 0.010 |
Why?
| | Fibroblast Growth Factor 7 | 1 | 1996 | 16 | 0.010 |
Why?
| | Fibroblast Growth Factor 10 | 1 | 1996 | 24 | 0.010 |
Why?
| | Chi-Square Distribution | 1 | 1998 | 499 | 0.010 |
Why?
| | Substance Abuse, Intravenous | 1 | 1998 | 99 | 0.010 |
Why?
| | Polymers | 1 | 2000 | 464 | 0.010 |
Why?
| | Lymph Nodes | 1 | 1998 | 423 | 0.010 |
Why?
| | Syndrome | 1 | 1996 | 339 | 0.010 |
Why?
| | Tensile Strength | 1 | 1996 | 103 | 0.010 |
Why?
| | Digestive System Surgical Procedures | 1 | 1996 | 89 | 0.010 |
Why?
| | Gene Expression Regulation | 1 | 2004 | 2353 | 0.010 |
Why?
| | DNA Primers | 1 | 1996 | 514 | 0.010 |
Why?
| | Phylogeny | 1 | 1999 | 805 | 0.010 |
Why?
| | Pharyngeal Neoplasms | 1 | 1995 | 3 | 0.010 |
Why?
| | Mice, Inbred C57BL | 1 | 2004 | 4773 | 0.010 |
Why?
| | Translocation, Genetic | 1 | 1995 | 93 | 0.010 |
Why?
| | Algorithms | 1 | 2002 | 1490 | 0.010 |
Why?
| | DNA-Binding Proteins | 1 | 2001 | 1316 | 0.010 |
Why?
| | Denture, Partial | 1 | 1994 | 1 | 0.010 |
Why?
| | Laryngeal Neoplasms | 1 | 1995 | 27 | 0.010 |
Why?
| | Vincristine | 1 | 1995 | 96 | 0.010 |
Why?
| | Dental Prosthesis | 1 | 1994 | 2 | 0.010 |
Why?
| | Histological Techniques | 1 | 1994 | 40 | 0.010 |
Why?
| | Patch Tests | 1 | 1994 | 52 | 0.010 |
Why?
| | Inflammation | 1 | 2004 | 2499 | 0.010 |
Why?
| | Aneuploidy | 1 | 1994 | 86 | 0.010 |
Why?
| | HIV Core Protein p24 | 1 | 1993 | 28 | 0.010 |
Why?
| | Homosexuality | 1 | 1993 | 16 | 0.010 |
Why?
| | Ki-1 Antigen | 1 | 1993 | 4 | 0.010 |
Why?
| | Gold | 1 | 1994 | 107 | 0.010 |
Why?
| | Bleomycin | 1 | 1995 | 232 | 0.010 |
Why?
| | Mucins | 1 | 1993 | 61 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 1998 | 1147 | 0.010 |
Why?
| | Chemotaxis, Leukocyte | 1 | 1993 | 130 | 0.010 |
Why?
| | Base Sequence | 1 | 1996 | 2114 | 0.010 |
Why?
| | Leukocyte Count | 1 | 1993 | 294 | 0.010 |
Why?
| | Cell Cycle | 1 | 1995 | 546 | 0.010 |
Why?
| | Phagocytosis | 1 | 1993 | 355 | 0.010 |
Why?
| | Pregnancy | 1 | 2001 | 5548 | 0.010 |
Why?
| | Cell Survival | 1 | 1993 | 1024 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 1998 | 3580 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2000 | 4665 | 0.010 |
Why?
| | Saccharin | 1 | 1988 | 4 | 0.000 |
Why?
| | Tablets | 1 | 1988 | 36 | 0.000 |
Why?
| | DNA | 1 | 1994 | 1356 | 0.000 |
Why?
| | Theophylline | 1 | 1988 | 60 | 0.000 |
Why?
| | Sucrose | 1 | 1988 | 91 | 0.000 |
Why?
| | Neutrophils | 1 | 1993 | 1172 | 0.000 |
Why?
| | Solutions | 1 | 1988 | 150 | 0.000 |
Why?
| | Tomography, X-Ray Computed | 1 | 1996 | 2392 | 0.000 |
Why?
| | Anticonvulsants | 1 | 1988 | 181 | 0.000 |
Why?
| | Anti-Bacterial Agents | 1 | 1988 | 1484 | 0.000 |
Why?
|
|
Flaitz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|